Cargando…
Directed natural evolution generates a next-generation oncolytic virus with a high potency and safety profile
Oncolytic viruses (OVs) represent a type of encouraging multi-mechanistic drug for the treatment of cancer. However, attenuation of virulence, which is generally required for the development of OVs based on pathogenic viral backbones, is frequently accompanied by a compromised killing effect on tumo...
Autores principales: | Guo, Li, Hu, Cheng, Liu, Yang, Chen, Xiaoyu, Song, Deli, Shen, Runling, Liu, Zhanzhen, Jia, Xudong, Zhang, Qinfen, Gao, Yuanzhu, Deng, Zhezhi, Zuo, Tao, Hu, Jun, Zhu, Wenbo, Cai, Jing, Yan, Guangmei, Liang, Jiankai, Lin, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256765/ https://www.ncbi.nlm.nih.gov/pubmed/37296165 http://dx.doi.org/10.1038/s41467-023-39156-3 |
Ejemplares similares
-
Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumors
por: Song, Deli, et al.
Publicado: (2022) -
Lonidamine potentiates the oncolytic efficiency of M1 virus independent of hexokinase 2 but via inhibition of antiviral immunity
por: Cai, Jing, et al.
Publicado: (2020) -
Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1
por: Cai, Jing, et al.
Publicado: (2020) -
Evolution for the Next Generation
por: Kawata, Masakado
Publicado: (2004) -
A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1
por: Li, Kai, et al.
Publicado: (2016)